GlassScriptPhysician profile
Joseph J Furlin
NPI 1316988389
$14,788.14
in general payments reported to CMS, 2019-2025
19 companies · $607 in 2025
The $607 reported for 2025 was more than what 84% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $35.03 · 2021: $65.52 · 2022: $13K · 2023: $411 · 2024: $382 · 2025: $607.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,313 · Education: $87.89.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,312.93 |
| Education | $87.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $13,207.27 | 2022-2023 | Da Vinci Surgical System |
| Exeltis, USA INC. | $516.27 | 2020-2025 | Slynd, Tyblume |
| Mayne Pharma Commercial LLC | $191.52 | 2025 | |
| Hologic Sales and Service, LLC | $172.86 | 2022-2025 | Acessa Provu System, Novasure, Myosure Tissue Removal Device |
| Medtronic, INC. | $104.54 | 2023 | Truclear |
| Conmed Corporation | $101.79 | 2022-2023 | Airseal |
| Astellas Pharma US INC | $89.07 | 2023-2025 | Veozah |
| Coopersurgical, INC. | $51.58 | 2021-2025 | Paragard T 380a, Paragard T 380a |
| Bayer Healthcare Pharmaceuticals INC. | $49.90 | 2023 | |
| Amgen INC. | $45.01 | 2023-2024 | Evenity, Prolia |
| Avion Pharmaceuticals | $42.68 | 2021-2022 | |
| Abbvie INC. | $39.19 | 2020-2023 | |
| Sumitomo Pharma America, INC. | $37.50 | 2024 | Myfembree |
| Dexcom, INC. | $35.74 | 2025 | Dexcom G6 Transmitter |
| Pfizer INC. | $24.97 | 2024 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alydia Health | $23.46 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $19.86 | 2025 | Exparel |
| Biogen, INC. | $18.34 | 2025 | Zurzuvae |
| Lsi Solutions INC | $16.59 | 2024 | Fornisee |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Furlin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.